This is TREAT-NMD webpage, where it can be found relevant information how to find biomaterials for The basic scientific research being carried out on Neuromuscular Diseases. It can work also as inspiration for investigators conduting reasech in others rare diseases
View this resource Bookmark this resourceDisease or Translational Resources
In this section you will have the opportunity to explore information regarding:
Patient registries,
Natural history,
Patients’ information as organizations, toolkits for patients, new-born screening programs, undiagnosed diseases programs (UDPs), EU planned cross-border treatment
Target Patient Value Profile
Databases/Tools (ODDG)
Networks
Biobanks
Biomarkers (Development, guidelines, validation, qualification, genomic, cancer, pain therapeutics)
Boosting delivery of rare disease therapies: the IRDiRC Orphan Drug Development Guidebook
Published by IRDiRC
Database or ToolResearch and Drug DevelopmentThis review describes IRDiRC Guidebook to facilitate drug development for rare diseases by organizing available tools into a standardized framework.
View this resource Bookmark this resource
Biomarker Validation
Published by Research Advocacy Network
BiomarkerBiomarker ValidationCancer DiseaseDrug Development ToolPreclinicalResearch and Drug DevelopmentThis is a review about biomarkers definition and the components of validity. It examines the methods by which biomarkers are validated and consider some examples of cancer biomarkers in use today. It concludes with information about situations where advocates might find this information useful.
View this resource Bookmark this resourceBiomarker Development Guide
Bookmark this resourceit reviews the steps of biomarker development, highlights the key issues in successful validation and implementation, and overviews representative examples in the oncology field. Regulatory issues and future perspectives in the era of big data analysis and precision medicine are discussed.
View this resource Bookmark this resource
Title of the Galaxy Guide (full): Orphan Drug Development Guide
Published by
Databases or ToolsIRDIRCOrphan Drug Development GuideResearch and Drug DevelopmentDescription of the Galaxy Guide
Bookmark this resource
Rare disease research: what industry contributes in knowledge and resources
Published by
European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug DevelopmentThis webinar highlighted how industry contributes to PPPs beyond funding, and provided attendees with examples of how industry has brought value to research projects conducted with European Research Networks (ERNs) in recent years.
View this resource Bookmark this resource
ERNs: a key EU infrastructure to partner for research activities, the why and the how
Published by
European Reference NetworkIndustry collaborationRare DiseaseResearch and Drug DevelopmentThe resource explains that European Reference Networks (ERNs) are a major EU healthcare and research infrastructure that bring together clinical expertise, data and specialised resources across Europe to tackle rare and complex diseases and are valuable partners for collaborative research activities. It emphasises the untapped potential of ERNs to engage with the pharmaceutical and biotech sectors, advocating for greater awareness and public–private partnerships to accelerate rare disease research and development and benefit patients
View this resource Bookmark this resource
What can the conect4children Stichting (c4c-S) do for ERNs
Published by
C4CClinical Research NetworkEuropean Reference NetworkNetworkOrphan DrugpaediatricRare DiseaseResearch and Drug Developmentconect4children Stichting (c4c-S) is a non-profit, pan-European organisation that supports paediatric clinical research by providing expert advice and trial support services, including feasibility assessments and site identification, for ERNs and other stakeholders. Building on a successful public–private partnership, it mobilises a large network of experts and research-ready sites to improve the efficiency and quality of paediatric trials across Europe.
View this resource Bookmark this resource
Tool 2: Examples of Initiatives which Foster Public-Private Partnerships in Rare Disease and Complementary Areas
Published by
European Reference NetworkEuropean UnionIndustry collaborationNetworkRare DiseaseResearch and Drug DevelopmentThis resource presents examples of programmes and structures which facilitate public private partnerships in rare disease or a complimentary area.
View this resource Bookmark this resource
